Tipper J, Kaufman S
Laboratory of Neurochemistry, National Institute of Mental Health, Bethesda, Maryland 20892.
J Biol Chem. 1992 Jan 15;267(2):889-96.
Rats were given intraperitoneal injections of 2 mCi of carrier-free 32Pi and substances known to activate liver phenylalanine hydroxylase. After 30 min, these animals were anesthetized and their livers removed for analysis of enzyme activity, 32Pi incorporation into immunoprecipitated phenylalanine hydroxylase and [gamma-32P]ATP specific activity. Following glucagon treatment, rat liver phenylalanine hydroxylase activity was stimulated more than 6-fold when assayed in the presence of the natural cofactor, tetrahydrobiopterin (BH4). Glucagon injection also resulted in an incorporation of 0.41 mol of 32Pi/mol of hydroxylase subunit (approximately 50,000 Da). In vivo stimulation of phenylalanine hydroxylase activity and 32Pi incorporation by glucagon had been previously observed in this laboratory (Donlon, J., and Kaufman, S. (1978) J. Biol. Chem. 253, 6657-6659). However, we show for the first time in the present study that in vivo treatment with phenylalanine alone results in a 4-fold increase in the BH4-dependent activity of phenylalanine hydroxylase concomitant with a significant incorporation of phosphate into phenylalanine hydroxylase (0.51 mol of 32Pi/mol of hydroxylase subunit). It is further demonstrated in vivo that the combined treatment with phenylalanine and glucagon results in a greater than 10-fold stimulation of BH4-dependent activity and the greatest level of 32Pi incorporation (0.75 mol of 32Pi/mol of hydroxylase subunit). Phenylalanine did not produce an elevation in plasma glucagon in these animals. A model is, thereby, proposed with respect to the ligand binding effects of phenylalanine on the state of phosphorylation and activation of phenylalanine hydroxylase. The significance of these regulatory roles are considered in light of the probable physiological environment of the enzyme.
给大鼠腹腔注射2毫居里无载体的32P i以及已知能激活肝脏苯丙氨酸羟化酶的物质。30分钟后,将这些动物麻醉并取出肝脏,用于分析酶活性、32P i掺入免疫沉淀的苯丙氨酸羟化酶中的情况以及[γ-32P]ATP的比活性。用胰高血糖素处理后,在天然辅因子四氢生物蝶呤(BH4)存在的情况下测定时,大鼠肝脏苯丙氨酸羟化酶活性被刺激了6倍以上。注射胰高血糖素还导致每摩尔羟化酶亚基(约50,000道尔顿)掺入0.41摩尔的32P i。先前在本实验室已观察到胰高血糖素在体内对苯丙氨酸羟化酶活性和32P i掺入的刺激作用(唐隆,J.,和考夫曼,S.(1978年)《生物化学杂志》253,6657 - 6659)。然而,在本研究中我们首次表明,仅用苯丙氨酸进行体内处理会使苯丙氨酸羟化酶依赖BH4的活性增加4倍,同时有大量磷酸盐掺入苯丙氨酸羟化酶(每摩尔羟化酶亚基0.51摩尔32P i)。体内进一步证明,苯丙氨酸和胰高血糖素联合处理导致依赖BH4的活性有超过10倍的刺激,且32P i掺入水平最高(每摩尔羟化酶亚基0.75摩尔32P i)。这些动物中苯丙氨酸并未使血浆胰高血糖素升高。由此提出了一个关于苯丙氨酸对苯丙氨酸羟化酶磷酸化状态和激活的配体结合效应的模型。根据该酶可能的生理环境考虑了这些调节作用的意义。